Search

Your search keyword '"Lin, A. B."' showing total 760 results

Search Constraints

Start Over You searched for: Author "Lin, A. B." Remove constraint Author: "Lin, A. B." Database Unpaywall Remove constraint Database: Unpaywall
760 results on '"Lin, A. B."'

Search Results

3. Changes in Lipid Profiles with the Progression of Pregnancy in Black Women

4. Assessment of neurovascular uncoupling: APOE status is a key driver of early metabolic and vascular dysfunction

6. LXR/CD38 activation drives cholesterol-induced macrophage senescence and neurodegeneration via NAD+ depletion

9. Building capacity for climate adaptation planning in protected area management: Options and challenges for World Heritage

13. A systematic search and narrative review of Aboriginal and Torres Strait Islander women and men pelvic health care: demonstrated need for improvement

15. Assessment of Neurovascular Uncoupling: APOE Status is a Key Driver of Early Metabolic and Vascular Dysfunction

16. Dietary fish oil enriched in very-long-chain polyunsaturated fatty acid reduces cardiometabolic risk factors and improves retinal function

24. Pandemic gardening: A narrative review, vignettes and implications for future research

26. Holistic climate change adaptation for World Heritage

29. Cover Image, Volume 36, Issue 5

30. Data from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

31. Supplementary Figures 1 and 2 and Supplementary Tables 1 through 3 from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

32. Data from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

33. Supplementary Table 2 from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

34. Supplementary Table 2 from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

35. Supplementary Figures 1 and 2 and Supplementary Tables 1 through 3 from A Novel CDK9 Inhibitor Shows Potent Antitumor Efficacy in Preclinical Hematologic Tumor Models

46. 148P AdvanTIG-105: Phase Ib dose-expansion study of ociperlimab (OCI) + tislelizumab (TIS) with chemotherapy in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC)

Catalog

Books, media, physical & digital resources